Perfect Corp (NYSE:PERF) received shareholder approval for its proposed $2-per-share merger with ProjectNY, securing approximately 99.99% of votes cast at its extraordinary general meeting.
Cleveland-Cliffs (NYSE:CLF) reported $612 million in third-quarter adjusted EBITDA, exceeding its $575 million guidance, as revenue reached $5.6 billion.
IDEAYA Biosciences (NASDAQ:IDYA) reported a 57% eye preservation rate in its OptimUM-09 trial, alongside updated darovasertib findings from two metastatic uveal melanoma studies.
Takeda (NYSE:TAK) reported a 67% lower relative risk of ulcerative colitis complications with ENTYVIO-based treatment targeting disease clearance rather than symptomatic remission alone.
Eli Lilly (NYSE:LLY) reported that Omvoh met its Phase 3 SHINE-2 primary endpoint, with 50% of 52 pediatric responders achieving clinical remission at Week 52.
Brent crude fell US$2.29, or 2.08%, to US$107.57 per barrel on Monday after Washington waived key Russia sanctions.
AbbVie (NYSE:ABBV) reported a 40.5% endoscopic remission rate at Week 24 for investigational ABBV-466 in its 300-patient Phase 2a TARGET-CD Crohn's disease trial.
OpenWorld (NASDAQ:OPNW) signed a definitive agreement to acquire Blocksight, supporting two proposed tokenized financing programs worth up to US$1.13 billion combined.
Red Cat Holdings (NASDAQ:RCAT) proposed acquiring Steyr Motors for €39 per share in cash, representing a 28.9% premium to the Austrian manufacturer's October 16 closing price.
BW LPG (NYSE:BWLP) reported approximately US$164 million in third-quarter gross trading results from its Product Services segment, with estimated net profit reaching US$118 million.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
